Orphazyme announces the upcoming appointment of Andrew Mercieca to its Board of Directors
– DENMARK, Copenhagen – Orphazyme A/S (CPH: ORPHA), a late-stage biopharmaceutical company, today announced the appointment of Andrew Mercieca to its Board of Directors, effective on April 7, 2022, to succeed Catherine Moukheibir who will step down from the Board as of December 9, 2021.…